Legal Representation
Attorney
Allyn Taylor, Esq.
USPTO Deadlines
Application History
15 eventsDate | Code | Type | Description |
---|---|---|---|
May 2, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
May 2, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Sep 28, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Aug 3, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 3, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 29, 2010 | ALIE | A | ASSIGNED TO LIE |
Jun 29, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Jun 15, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 28, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
May 28, 2010 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
May 28, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
May 28, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
May 26, 2010 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 24, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 22, 2010 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...